Free Trial

eFFECTOR Therapeutics (EFTR) Institutional Ownership

$0.04
0.00 (0.00%)
(As of 07/11/2024 ET)

Institutional Ownership Changes (13F Filings) for eFFECTOR Therapeutics (NASDAQ:EFTR)

Current
Institutional Ownership
Percentage
57.67%
Number of
Institutional Buyers
(last 12 months)
2
Total
Institutional Inflows
(last 12 months)
$3.79M
Number of
Institutional Sellers
(last 12 months)
3
Total
Institutional Outflows
(last 12 months)
$88.94M
Get EFTR Insider Trade Alerts

Want to know when executives and insiders are buying or selling eFFECTOR Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

EFTR Institutional Buying and Selling by Quarter

eFFECTOR Therapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/16/2024Blackstone Inc.52,343$753K0.0%-96.0%1.419%
5/14/2024StemPoint Capital LP132,793$1.91M0.5%N/A3.599%
5/3/2024Carlyle Group Inc.192,884$2.72M0.2%-96.0%5.227%
11/13/2023Column Group LLC4,026,224$2.42M1.6%-6.6%9.496%
11/2/2023Sonora Investment Management Group LLC125,000$75K0.0%N/A0.295%
6/5/2023EP Wealth Advisors LLC17,607$1.65M0.0%N/A0.042%
5/5/2023Carlyle Group Inc.4,822,114$1.69M0.1%N/A11.373%
8/16/2022Callan Capital LLC20,000$28K0.0%N/A0.048%
8/2/2022Resolute Financial LLC30,000$43K0.0%N/A0.072%
8/1/2022Parallel Advisors LLC1,693,559$2.41M0.1%+150.0%4.092%
4/28/2022Parallel Advisors LLC677,452$2.74M0.1%N/A1.637%
2/15/2022SR One Capital Management LP6,822,114$56.49M31.9%N/A16.898%
2/9/2022Alps Advisors Inc.51,942$430K0.0%N/A0.129%
2/3/2022OUP Management Co. LLC1,025,697$8.49M3.8%N/A2.541%
11/16/2021Verition Fund Management LLC24,667$347K0.0%N/A0.061%
11/15/2021Abingworth LLP4,822,114$67.03M15.2%N/A11.964%
11/15/2021Sectoral Asset Management Inc2,882,744$40.50M3.4%N/A7.153%
(Data available from 1/1/2016 forward)

EFTR Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of EFTR shares?

During the previous two years, 9 institutional investors and hedge funds held shares of eFFECTOR Therapeutics. The most heavily invested institutionals were Carlyle Group Inc. ($2.72M), Column Group LLC ($2.42M), Parallel Advisors LLC ($2.41M), StemPoint Capital LP ($1.91M), EP Wealth Advisors LLC ($1.65M), Blackstone Inc. ($753K), and Sonora Investment Management Group LLC ($75K).Learn more on EFTR's institutional investors.

What percentage of eFFECTOR Therapeutics stock is owned by institutional investors?

57.67% of eFFECTOR Therapeutics stock is owned by institutional investors. Learn more on EFTR's institutional investor holdings.

Which institutional investors have been buying eFFECTOR Therapeutics stock?

The following institutional investors have purchased eFFECTOR Therapeutics stock in the last 24 months: Carlyle Group Inc. ($4.82M), Parallel Advisors LLC ($1.02M), StemPoint Capital LP ($132.79K), Sonora Investment Management Group LLC ($125K), Resolute Financial LLC ($30K), Callan Capital LLC ($20K), and EP Wealth Advisors LLC ($17.61K).

How much institutional buying is happening at eFFECTOR Therapeutics?

Institutional investors have bought a total of 6,163,621 shares in the last 24 months. This purchase volume represents approximately $84.31M in transactions.

Which eFFECTOR Therapeutics major shareholders have been selling company stock?

The following institutional investors have sold eFFECTOR Therapeutics stock in the last 24 months: Carlyle Group Inc. ($4.63M), Blackstone Inc. ($1.26M), and Column Group LLC ($283.11K).

How much institutional selling is happening at eFFECTOR Therapeutics?

Institutional investors have sold a total of 6,168,579 shares in the last 24 months. This volume of shares sold represents approximately $88.94M in transactions.


This page (NASDAQ:EFTR) was last updated on 7/12/2024 by MarketBeat.com Staff

From Our Partners